ArticleJournal of orthopaedic case reports2025
Humeroulnar Bridging Myositis Ossificans Traumatica: A Case Report.
Article in Journal of orthopaedic case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Myositis ossificans traumatica (MOT) of the elbow is a rare entity in children. It is a self-localized tumor-like lesion of the elbow causing ankylosis due to humeroulnar bridging. It is a complication arising due to a muscle contusion injury. Case Report: We report a case of an 8-year-old female who presented with a 2-year history of a fixed elbow and a palpable bony mass. The examination confirmed a confined bony mass on the anterior aspect and ankylosis of her left elbow. On confirmation of the diagnosis, an en bloc excision was performed. Follow-up every 2 weeks for the first 3 months, then once a month for the next 6 months, and finally once every 6 months for the next 4 years. The affected limb functioned well, with no sign of recurrence. Conclusion: MOTs of the elbow in children are a rarity, and excision of the lesion without delay is an effective management strategy for a satisfactory outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.